Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$444M |
| 2 |
Workday
WDAY
|
+$364M |
| 3 |
AbbVie
ABBV
|
+$340M |
| 4 |
Advanced Micro Devices
AMD
|
+$312M |
| 5 |
Synopsys
SNPS
|
+$302M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$1.81B |
| 2 |
Apple
AAPL
|
+$947M |
| 3 |
Boston Scientific
BSX
|
+$628M |
| 4 |
Microsoft
MSFT
|
+$585M |
| 5 |
Netflix
NFLX
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.62% |
| 2 | Healthcare | 18.99% |
| 3 | Consumer Discretionary | 10.82% |
| 4 | Financials | 10.24% |
| 5 | Industrials | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Bionano Genomics
BNGO
$12.2M
| $146K | ﹤0.01% |
94
| – | – |
|
2502
Senseonics Holdings Inc
SENS
$265M
| $145K | ﹤0.01% |
3,707
+1
| +0% | +$46 |
|
|
SCPL
2503
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $145K | ﹤0.01% |
+11,222
| New | +$142K |
|
2504
Allogene Therapeutics
ALLO
$680M
| $143K | ﹤0.01% |
+15,647
| New | +$163K |
|
|
SGMO
2505
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $143K | ﹤0.01% |
24,721
+8
| +0% | +$48 |
|
2506
BridgeBio Pharma
BBIO
$16.1B
| $141K | ﹤0.01% |
13,848
-14
| -0.1% | -$144 |
|
2507
RPC Inc
RES
$1.2B
| $141K | ﹤0.01% |
13,167
+13
| +0.1% | +$104 |
|
2508
AEye
LIDR
$50.9M
| $140K | ﹤0.01% |
860
| – | – |
|
2509
Helix Energy Solutions
HLX
$1.36B
| $139K | ﹤0.01% |
29,073
+5
| +0% | +$21 |
|
2510
Accel Entertainment
ACEL
$973M
| $138K | ﹤0.01% |
11,374
+3
| +0% | +$39 |
|
|
AMRS
2511
DELISTED
Amyris Inc.
AMRS
| $138K | ﹤0.01% |
31,748
+38
| +0.1% | +$171 |
|
|
HTBK
2512
DELISTED
Heritage Commerce
HTBK
| $137K | ﹤0.01% |
12,156
+2
| +0% | +$24 |
|
2513
Atara Biotherapeutics
ATRA
$73.6M
| $135K | ﹤0.01% |
+581
| New | +$185K |
|
2514
WisdomTree
WT
$2.88B
| $135K | ﹤0.01% |
22,877
+5
| +0% | +$29 |
|
2515
Hippo Holdings
HIPO
$830M
| $133K | ﹤0.01% |
2,686
-41
| -2% | -$2.12K |
|
|
CTEV
2516
Claritev Corp
CTEV
$402M
| $133K | ﹤0.01% |
+714
| New | +$118K |
|
2517
OneSpaWorld
OSW
$2.64B
| $132K | ﹤0.01% |
12,976
| – | – |
|
2518
Invesco Mortgage Capital
IVR
$759M
| $131K | ﹤0.01% |
5,786
+14
| +0.2% | +$345 |
|
|
EGIO
2519
DELISTED
Edgio, Inc. Common Stock
EGIO
| $131K | ﹤0.01% |
631
+2
| +0.3% | +$333 |
|
|
ATRS
2520
DELISTED
Antares Pharma, Inc.
ATRS
| $131K | ﹤0.01% |
32,202
-117,730
| -79% | -$427K |
|
2521
Stagwell
STGW
$2.1B
| $130K | ﹤0.01% |
17,865
-1,048
| -6% | -$7.87K |
|
|
FFAI
2522
Faraday Future Intelligent Electric
FFAI
$13.7M
| – | – |
0
| – | – |
|
2523
Oscar Health
OSCR
$9.42B
| $129K | ﹤0.01% |
12,952
-365,545
| -97% | -$2.72M |
|
2524
Nuvation Bio
NUVB
$2.33B
| $127K | ﹤0.01% |
+24,218
| New | +$136K |
|
2525
Ocugen
OCGN
$427M
| $126K | ﹤0.01% |
+38,244
| New | +$134K |
|
Similar funds
Janus Henderson Group's Q1 2022 Portfolio in Review
As of Q1 2022, Janus Henderson Group held 2,774 positions worth $207B, down 14% from $240B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Janus Henderson Group withdrew a net $13B in Q1 2022, closing 135 positions and reducing 1,078 holdings. Its most notable exit was Xilinx Inc, an estimated $378M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Janus Henderson Group opened a new position in Tricon Residential Inc. worth $36M.
- Janus Henderson Group's largest Q1 2022 buy was Tricon Residential Inc.: 2,264,492 shares worth $36M.
- Janus Henderson Group added most to Atlassian in Q1 2022, an estimated $444M increase.
- Janus Henderson Group's biggest Q1 2022 reduction was Adobe, cutting an estimated $1.81B.
- Janus Henderson Group fully exited Xilinx Inc in Q1 2022, selling an estimated $378M.
- Janus Henderson Group's ten largest holdings make up 25% of its $207B portfolio in Q1 2022.
- Janus Henderson Group opened 230 new positions and closed 135 in Q1 2022.
- Janus Henderson Group's portfolio value fell 14% quarter-over-quarter to $207B.
Based on Janus Henderson Group's 13F filing for Q1 2022, filed 16 May 2022.